Open AccessReview of epidermal growth factor receptor-tyrosine kinase inhibitors administration to non-small-cell lung cancer patients undergoing hemodialysis
Author(s) -
Chou-Chin Lan,
PoChun Hsieh,
Ching Feng Huang,
Mei-Chen Yang,
WenLin Su,
ChihWei Wu,
Yao-Kuang Wu
Publication year - 2022
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v10.i19.6360
Subject(s) - medicine , lung cancer , epidermal growth factor receptor , hemodialysis , tyrosine kinase , adverse effect , oncology , gefitinib , renal function , erlotinib , tyrosine kinase inhibitor , cancer , receptor